To this end, approximately 5% of CD4+ T cells in most COVID-19 cases are specific for ORF8 protein, and ORF8 protein accounts for 10% of CD8+ T cell reactivity in COVID-19 recovered subjects [87, 88]. This evidence concerns the gene CD4 and COVID-19.